The Importance of Antibody Isotype in HIV-1 Virus Capture Assay and in TZM-bl Neutralization

被引:4
|
作者
Peachman, Kristina K. [2 ]
Wieczorek, Lindsay [2 ]
Matyas, Gary R.
Polonis, Victoria R.
Alving, Carl R.
Rao, Mangala [1 ]
机构
[1] Walter Reed Army Inst Res, Dept Adjuvant & Antigen Res, Div Retrovirol, US Mil HIV Res Program, Rockville, MD 20850 USA
[2] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; LIPID EPITOPES; MONOCLONAL-ANTIBODIES; SIMULTANEOUSLY BIND; TYPE-1; LIPOSOMES; PROTEIN; INTACT; 2F5; PHOSPHOINOSITIDES;
D O I
10.1089/vim.2010.0061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The binding of murine IgM mAbs to five different clades of HIV-1 was examined using a modified ELISA-based virus capture assay. Two murine multispecific IgM mAbs that exhibit both lipid and gp41 epitope specificities, and one murine IgM mAb that exhibits lipid-binding specificity, were utilized. The binding of the IgG and the IgM isotypes of human mAb 2F5 to clades A through AE were also evaluated. The binding of 2F5 to HIV-1 was dependent upon the antibody isotype. Monoclonal IgM antibodies bound significantly lower amounts of HIV-1 than the corresponding IgG isotype. Although murine IgM mAbs bound HIV-1 to varying degrees in the virus capture assay, they failed to neutralize HIV-1 in a TZM-bl pseudovirus assay. In contrast, 2F5-IgM mAb bound certain HIV-1 isolates, and also neutralized them, although not as efficiently as the 2F5-IgG isotype. Studies on the relationship between virus binding and neutralization in a TZM-bl pseudovirus assay indicated that in most cases, mAbs that exhibited neutralization also bound the virus.
引用
收藏
页码:627 / 632
页数:6
相关论文
共 50 条
  • [41] Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling
    Wieczorek, Lindsay
    Brown, Bruce K.
    Macedo, Camila DelSarto
    Wesberry-Schmierer, Maggie
    Ngauy, Viseth
    Borges, Andrew Rosa
    Michael, Nelson L.
    Marovich, Mary A.
    Montefiori, David C.
    Polonis, Victoria R.
    VIROLOGY, 2013, 447 (1-2) : 240 - 248
  • [42] Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
    Pinto, Dora
    Fenwick, Craig
    Caillat, Christophe
    Silacci, Chiara
    Guseva, Serafima
    Dehez, Francois
    Chipot, Christophe
    Barbieri, Sonia
    Minola, Andrea
    Jarrossay, David
    Tomaras, Georgia D.
    Shen, Xiaoying
    Riva, Agostino
    Tarkowski, Maciej
    Schwartz, Olivier
    Bruel, Timothee
    Dufloo, Jeremy
    Seaman, Michael S.
    Montefiori, David C.
    Lanzavecchia, Antonio
    Corti, Davide
    Pantaleo, Giuseppe
    Weissenhorn, Winfried
    CELL HOST & MICROBE, 2019, 26 (05) : 623 - +
  • [43] Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity
    Bradley, Todd
    Trama, Ashley
    Tumba, Nancy
    Gray, Elin
    Lu, Xiaozhi
    Madani, Navid
    Jahanbakhsh, Fatemeh
    Eaton, Amanda
    Xia, Shi-Mao
    Parks, Robert
    Lloyd, Krissey E.
    Sutherland, Laura L.
    Scearce, Richard M.
    Bowman, Cindy M.
    Barnett, Susan
    Abdool-Karim, Salim S.
    Boyd, Scott D.
    Melillo, Bruno
    Smith, Amos B., III
    Sodroski, Joseph
    Kepler, Thomas B.
    Alam, S. Munir
    Gao, Feng
    Bonsignori, Mattia
    Liao, Hua-Xin
    Moody, M. Anthony
    Montefiori, David
    Santra, Sampa
    Morris, Lynn
    Haynes, Barton F.
    EBIOMEDICINE, 2016, 12 : 196 - 207
  • [44] Evaluation of two HIV antibody confirmatory assays: Geenius™ HIV1/2 Confirmatory Assay and the recomLine HIV-1 & HIV-2 IgG Line Immunoassay
    Friedrichs, I.
    Buus, C.
    Berger, A.
    Keppler, O. T.
    Rabenau, H. F.
    JOURNAL OF VIROLOGICAL METHODS, 2015, 224 : 91 - 94
  • [45] Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells
    Rao, Priyanka Gadam
    Lambert, Gregory S.
    Upadhyay, Chitra
    JOURNAL OF VIROLOGY, 2023,
  • [46] Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells
    Rao, Priyanka Gadam
    Lambert, Gregory S.
    Upadhyay, Chitra
    JOURNAL OF VIROLOGY, 2023, 97 (09)
  • [47] Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design
    Chen, Weizao
    Ying, Tianlei
    Dimitrov, Dimiter S.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (05) : 657 - 671
  • [48] Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay
    Opalka, D
    Pessi, A
    Bianchi, E
    Ciliberto, G
    Schleif, W
    McElhaugh, M
    Danzeisen, R
    Geleziunas, R
    Miller, M
    Eckert, DM
    Bramhill, D
    Joyce, J
    Cook, J
    Magilton, W
    Shiver, J
    Emini, E
    Esser, MT
    JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 287 (1-2) : 49 - 65
  • [49] Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus
    Mayr, Luzia M.
    Powell, Rebecca L.
    Ngai, Johnson N.
    Takang, William A.
    Nadas, Arthur
    Nyambi, Phillipe N.
    PLOS ONE, 2012, 7 (06):
  • [50] Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections
    Njai, H. F.
    Tomusange, K.
    Sokolik-Wolak, B.
    Montefiori, D.
    Balla, S.
    Vanham, G.
    Levin, J.
    Maher, D.
    Kamali, A.
    Grosskurth, H.
    Pala, P.
    Kaleebu, P.
    RETROVIROLOGY, 2009, 6